Journal of Hard Tissue Biology
Online ISSN : 1880-828X
Print ISSN : 1341-7649
ISSN-L : 1341-7649
International Symposium of Maxillofacial and Oral Regenerative Biology in Okayama 2005
Examination of The Cevimeline Hydrochloride Hydrate Concomitant Hachiazule and Xylocaine Gargle Therapy
Hiroshi MeseKatsushi FurunoAkira Sasaki
著者情報
ジャーナル フリー

2005 年 14 巻 2 号 p. 56-57

詳細
抄録
A gargling treatment by Hachiazele and Xylocaine is useful for a stomatitis treatment of the oral cancer patient with chemotherapy and/or radiotherapy. However, there is a little improvement of dry mouth. Aiming at improvement of dry mouth for the oral cancer patient with chemotherapy and/or radiotherapy, we reviewed the cevimeline hydrochloride hydrate concomitant Hachiazule and Xylocaine gargling therapeutic safety. Homeostasis for ten days of cevimeline hydrochloride hydrate was confirmed in all condition by an incompatibility examination. It was significant, and the group of cevimeline hydrochloride hydrate combination elevated salivation dosage in comparison with a non-concomitant group. In addition, the side effect did not accept both groups together. As for the cevimeline hydrochloride hydrate combination Haciazule and Xylocaine gargling treatment, it was thought that beneficial gargling was therapeutic for dry mouth of the oral cancer patient with chemotherapy and/or radiotherapy.
著者関連情報
© 2005 by The Hard Tissue Biology Network Association(JHTBNet)
前の記事 次の記事
feedback
Top